Bravecto 20 – 40K

1,000.00EGP

Flea and Tick Chart

SKU: 3424 Categories: , Tag:

BRAVECTO 1-MONTH Chews: indicated for dogs 8 weeks of age and older. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. BRAVECTO 1-MONTH is not effective against A. americanum in puppies less than 6 months of age. BRAVECTO Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated.

BRAVECTO has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. BRAVECTO Chews and Topical Solution for dogs is not effective against the lone star tick beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS has not been established in breeding, pregnant, and lactating cats.

All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class.  This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.

Reviews

There are no reviews yet.

Be the first to review “Bravecto 20 – 40K”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsBravecto 20 - 40K removeFipron Spot-On For Medium Dog Weighing 10-20K removeBioFax Against Fleas and Ticks for Adult Dog removeBravecto 40 - 56K removeVera Shampoo Anti Fleas 200ml removeScalibor 48Cm remove
ImagePlaceholderPlaceholderPlaceholderPlaceholderPlaceholderPlaceholder
SKU34242266199134253500951
Rating
Price1,000.00EGP200.00EGP55.00EGP1,000.00EGP60.00EGP300.00EGP
Stock
Availability
Add to cart

Add to cart

Add to cart

Add to cart

Add to cart

Add to cart

Add to cart

DescriptionFlea and Tick Chart1 single-dose tube. 134 mg spot on solution for dog M. solution for application on skin. Treatment and prevention of flea infestation and related flea allergy dermatitis in dogs Treatment and prevention of infestation by ticks and lice in dogs.BioFax for dogs is designed to get rid of parasites (such as ticks, fleas, etc.) as well as from stinging insects such as mosquitoes thanks to its repellent formula.Flea and Tick Chart
  • Made in Egypt
Carton containing one 48 cm collar.
Content

BRAVECTO 1-MONTH Chews: indicated for dogs 8 weeks of age and older. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. BRAVECTO 1-MONTH is not effective against A. americanum in puppies less than 6 months of age. BRAVECTO Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated.

BRAVECTO has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. BRAVECTO Chews and Topical Solution for dogs is not effective against the lone star tick beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS has not been established in breeding, pregnant, and lactating cats.

All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class.  This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.

134mg For dogs weighing 10 - 20 kg protection against fleas up to 60 days for ticks to 30 days Active ingredient: fipronil high efficiency, safe, pleasant application recommended dose is contained in a single tube a volume of 1,34 ml tear, self-adhesive label in vaccination certificate is included with each tube السعر للامبول الواحد

For dogs weighing 10 - 20 kg.

                                         Active substance:

                                            Fipronil 134 mg

Method of administration: spot-on solution for spotting.

Protection against fleas up to 60 days, against ticks and ticks up to 30 days, depending on the environmental pollution. Fleas are sacrificed within 24 hours of administration  
  After applying it to the dog's skin, its active ingredients penetrate and spread through the dog's skin and fur to kill ticks and fleas within 24 hours. And the effect of the points continues after 30 days. One ampoule is used for dogs from 10 kg to 15 kg. Ambulan is used for dogs from 16 kg to 30 kg. Use three ampoules from 31 kg to 45 kg.

BRAVECTO 1-MONTH Chews: indicated for dogs 8 weeks of age and older. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. BRAVECTO 1-MONTH is not effective against A. americanum in puppies less than 6 months of age. BRAVECTO Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated.

BRAVECTO has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. BRAVECTO Chews and Topical Solution for dogs is not effective against the lone star tick beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS has not been established in breeding, pregnant, and lactating cats.

All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class.  This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.

Presentation

White medicated collar of smooth consistency with a plastic buckle at one extremity.

Active ingredients

Collar for small and medium-sized dogs 48 cm in length (19 g) contains 0.76 g deltamethrin per collar. Collar for large dogs 65 cm in length (25 g) contains 1.0 g deltamethrin per collar.

Target species

Dogs

Indications for use

  • Control of infestations with ticks (Ixodes ricinus; Rhipicephalus sanguineus) for 5 to 6 months.
  • Control of blood sucking by phlebotomine sandflies (Phlebotomus perniciosus) for a period of 5 to 6 months.
  • Anti-feeding effect on adult mosquitoes of the species Culex pipiens pipiens for 6 months.

Packaging

Carton containing one 48 cm collar.
Weight
DimensionsN/AN/AN/AN/AN/AN/A
Additional information